| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Growth Officer | Chief Commercial Officer
1 company
Shah Pritesh is a Chief Growth Officer at NovoCure Ltd. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | NVCR Novocure Ltd | Chief Growth Officer | Sell | 382 | $12.65 | $4,832.30 | -0.3% | +6.7% | +40.6% | |
| Sep 1, 2023 | NVCR Novocure Ltd | Chief Growth Officer | Sell | 273 | $21.82 | $5,956.10 | -0.2% | -45.0% | -12.8% | |
| Mar 3, 2023 | NVCR Novocure Ltd | Chief Growth Officer | Sell | 21,421 | $76.16 | $1,631,410.51 | -5.0% | -4.2% | -79.2% | |
| Mar 2, 2023 | NVCR Novocure Ltd | Chief Growth Officer | Sell | 937 | $75.28 | $70,535.39 | -0.9% | -4.4% | -78.4% | |
| Mar 1, 2023 | NVCR Novocure Ltd | Chief Growth Officer | Sell | 1,923 | $76.36 | $146,844.90 | -1.9% | -6.9% | -79.9% | |
| Jan 5, 2023 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 387 | $108.00 | $41,796.00 | -0.5% | -47.7% | -88.8% | |
| Sep 2, 2022 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 269 | $79.04 | $21,260.95 | -0.3% | +3.7% | -71.7% | |
| Mar 9, 2022 | NVCR Novocure Ltd | Chief Commercial Officer | Sale+OE | 3,669 | $71.19 | $261,196.11 | -4.2% | +9.7% | -1.2% | |
| Mar 8, 2022 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 7,775 | $69.73 | $542,115.80 | -4.5% | +13.2% | +6.5% | |
| Mar 4, 2022 | NVCR Novocure Ltd | Chief Commercial Officer | Sell | 5,543 | $72.54 | $402,064.38 | -2.0% | +22.4% | +12.5% |